Telmisartan and Rosuvastatin Tablets 80/20 mg
Telmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
MFDS item code 202101728 · Approved 2021.02.22
This product's status changed to Expired on 2026.02.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and dyslipidemia; inhibition of atherosclerotic progression and reduction of cardiovascular disease risk
This medication is suitable for patients who need to use both telmisartan and rosuvastatin simultaneously. Telmisartan helps in the treatment of essential hypertension, especially effective in high-risk patients aged 55 and over who cannot use ACE inhibitors, reducing the risk of myocardial infarction, stroke, and death from cardiovascular diseases. Rosuvastatin is used as an adjunct to diet in the treatment of hypercholesterolemia and mixed hyperlipidemia, helping to lower total cholesterol and LDL cholesterol in patients with hypercholesterolemia, thus delaying the progression of atherosclerosis. Additionally, it is used to reduce the risk of cardiovascular disease and after procedures like stroke, myocardial infarction, and angioplasty. Therefore, this medication effectively improves the risk of cardiovascular diseases in patients with hypertension and hyperlipidemia.
This medication is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan/rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. This medication produces an additional blood pressure-lowering effect when administered with thiazide diuretics such as hydrochlorothiazide. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medication to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medications may be needed. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 2. Older adults: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medication at 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 5. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medication (a combination product with the same amounts of each active ingredient) for convenience.
This medication can cause serious harm to the fetus and newborn if used during pregnancy, so it should be stopped immediately if pregnancy is confirmed. Women who are allergic to this medication, pregnant, breastfeeding, or of childbearing age not using adequate contraception should not take it. Patients with severe liver or kidney dysfunction, certain blood disorders, or muscle diseases should not take this medication. Elderly patients, those with high potassium levels, and patients with mild to moderate liver impairment should use this medication cautiously and require monitoring of liver function tests and muscle-related symptoms. This medication may cause side effects such as muscle pain, liver function abnormalities, dizziness, dyspepsia, etc., and immediate consultation with a physician is necessary if such symptoms occur. Particularly in cases of severe muscle pain or weakness, a test for muscle damage (increased CK levels) should be conducted, and the medication should be discontinued if needed. This medication may interact with other medications, so patients must inform their healthcare providers about any other medications they are taking. Caution should be exercised as drowsiness or dizziness may occur while driving or operating machinery. It is essential to have regular blood tests and liver function tests while taking this medication, and immediate consultation with healthcare providers is crucial if any abnormal symptoms appear. Safety and effectiveness in children have not been established, and usage is not recommended. In case of overdose, symptoms such as hypotension, dizziness, and acute kidney failure may occur, and appropriate treatment at a medical institution should be pursued immediately. This medication should be stored out of the reach of children, and it is advisable not to transfer it to another container.
Increased ALT, Increased AST, Increased serum creatine phosphokinase (CPK), Dizziness, Itching, Dyspepsia, Oral paresthesia, Musculoskeletal stiffness, Acne, Nasopharyngitis, Increased serum potassium, Glycosuria, Dysuria, Rhinitis, Oropharyngeal discomfort, Pulmonary disease, Unspecified gastrointestinal disease, Benign gastrointestinal neoplasm, Hemorrhoids, Skeletal pain, Osteoporosis, Sensory reduction, Movement disorders, Atherosclerosis, Frequent urination, Tinnitus, Hearing reduction, Halitosis, Fatty liver, Upper respiratory tract infection, Pharyngitis, Sinusitis, Urinary tract infection, Cystitis, Sepsis, Anemia, Thrombocytopenia, Eosinophilia, Hypersensitivity, Anaphylactic reaction, Hyperkalemia, Hypoglycemia, Depression, Insomnia, Anxiety, Syncope, Visual disturbances, Dizziness, Bradycardia, Tachycardia, Hypotension, Orthostatic hypotension, Dyspnea, Abdominal pain, Diarrhea, Abdominal bloating, Vomiting, Abdominal discomfort, Dry mouth, Liver dysfunction, Hepatic impairment, Increased sweating, Rash, Erythema, Angioedema, Drug rash, Toxic skin rash, Eczema, Urticaria, Myalgia, Back pain, Muscle cramps, Arthralgia, Limb pain, Tendon pain, Acute kidney failure, Chest pain, Weakness, Influenza-like illness, Increased serum creatinine, Increased serum uric acid, Increased liver enzymes, Elevated serum CK, Decreased hemoglobin, Headache, Facial spasms, Paresthesia, Paralysis, Cough, Hyperventilation, Pneumonia, Flushing, Erectile dysfunction, Loss of appetite, Arrhythmia, Weakness, Edema, Decreased libido, Facial edema, Alopecia, Conjunctivitis, Noises in the ear, Petechiae, Constipation, Nausea, Pancreatitis, Myopathy, Rhabdomyolysis, Weakness, Headache, Myalgia, Increased CK, Constipation, Increased AST, Weakness, Arthralgia, Fatigue, Numbness, Paresthesia, Chest discomfort, Nausea, Abdominal pain, Diarrhea, Loss of appetite, Abdominal bloating, Syncope, Generalized pain, Muscle cramps, Gout, Erectile dysfunction, Angioedema, Diabetes, Headache, Dizziness, Constipation, Nausea, Abdominal pain, Stevens-Johnson syndrome, Drug reaction with eosinophilia and systemic symptoms, Lupus-like syndrome, Muscle rupture, Arthralgia, Immune-mediated necrotizing myopathy, Hematuria, Edema, Depression, Sleep disturbances, Sexual dysfunction, Gynecomastia, Fatal and non-fatal liver failure, Impaired memory, Amnesia, Memory loss, Memory disturbances, Confusion, Severe myasthenia, Ocular myasthenia, Hypotension, Tachycardia, Bradycardia, Acute kidney failure, Shock, Loss of consciousness, Liver dysfunction, Jaundice, Anaphylactoid symptoms, Interstitial pneumonia, Rhabdomyolysis, Palpitations, Fatigue, Nausea, Inadequate response, Headache, Cough, Palpitations, Myalgia, Arthralgia, Thrombocytopenia, Increased serum creatinine, Acute kidney failure, Oliguria
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain room temperature between 1 and 30 degrees Celsius.
Pale pink oval film-coated tablet
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.